IMMUNOPHARMACOLOGY Flashcards
GLUCOCORTICOID
MAIN ACTION
GLUCOCORTICOID
- have broad anti-inflammatory effects + immunosuppressive effects
- glucocorticoids act by binding to the cytosolic glucocorticoid receptor
- The glucocorticoid-glucocorticoid receptor complex translocates to the nucleus and binds to glucocorticoid response elements (GREs) in the promoter region of specific genes, either up- regulating or down-regulating gene expression.
PREDNISONE
MOA
ANTI-INFLAMMATORY MECHANISM OF ACTION OF GLUCOCORTICOIDS
Glucocorticoids relieve pain due to the modulation of inflammatory responses. Glucocorticoids suppress several inflammatory pathways. They can inhibit prostaglandin synthesis through three independent mechanisms:
- INDUCTION of annexin I
Glucocorticoids induce synthesis of annexin I. Annexin I is an antiinflammatory protein that inhibits cytosolic phospholipase A2α (cPLA2α), thus blocking the release of arachidonic acid and its subsequent conversion to eicosanoids.
- INDUCTION of MAPK phosphatase 1
Glucocorticoid-induced MAPK phosphatase 1 dephosphorylates and inactivates MAPKs, thus inhibiting proinflammatory signaling pathways. MAPK phosphatase 1 may also inhibit cPLA2α activity by blocking its phosphorylation by MAPKs
- Repression of transcription of cyclooxygenase 2.
NF-kB is a transcription factor that stimulates transcription of cytokines and chemokines. NF-kB also induces the transcription of cyclooxygenase 2. Glucocorticoids inhibit NF-kB, thus reducing the expression of COX2
PREDISONE
USES
USES:
1) they RELIEVE PAIN d/t the modulation of infammatory responses, and suppress several inflammatory pathways
2) Used to TREAT AUTOIMMUNE DISORDERS such as RA, SLE, psoriasis, asthma, IBD
3) to PREVENT + TREAT TRANSPLANT REJECTION
4) In palliative care GLUCOCORTICOIDS are used to ALLEVIATE PAIN, NAUSEA, + FATIGUE
PREDNISONE
AE
GLUCOCORTICOID
ADVERSE EFFECTS:
SHORT-TERM USE: hypertension, hyperglycemia, immunosuppression, psychotic reactoins, and cognitive impairment
LONG-TERM USE: MYOPATHY, CUSHINGS SYNDROME, + OSTEOPOROSIS
-increased CORTISOL = CUSHING SYNDROME: Hypertension, weight gain, moon facies, truncal obesity A , buffalo hump, skin changes (thinning, striae), osteoporosis, hyperglycemia (insulin resistance), amenorrhea, immunosuppression.
CYCLOSPORIN
MOA
USES
Note: don’t confuse with cycloPHOSPHAMIDE
CALCINEURIN INHIBITOR = T CELL INHIBITOR
CYCLOSPORIN –> CYCLOPHILLIN (must fill up before you go) –> then CALCINEURIN (N UR IN!!!) is in with a chick. Sporin, Phill up, then Ur in! Inhibits NFAT (no fat chicks) –> inhibits IL-2,3, and gamma
Cyclosporine is a peptide antibiotic. Cyclosporine binds to CYCLOPHILLIN, a member of a class of intracellular proteins called immunophilins. Cyclosporine and cyclophilin form a COMPLEX –> inhibits the cytoplasmic phosphatase, CALCINEURIN, which is necessary for the activation of a T- cell-specific transcription factor. This transcription factor, NF-AT, is involved in the synthesis of interleukins (eg, IL-2) by activated T cells. Cyclosporine inhibits the gene transcription of IL-2, IL-3, IFN-γ, and other factors produced by antigen-stimulated T cells.
USES:
1) ORGAN TRANSPLANTATION
2) UVEITIS
3) RA
4) PSORIASIS
CYCLOSPORIN
AE
DRUG INTERACTIONS
ADVERSE EFFECTS
CYCLOSPORIN –> causes NEPHROTOXICITY (cyclo b/c your kidneys cycle your blood). Also, adverse effects of having a good date is you make her smile and you realise the GUM HYPERPLASIA. Although, she does have BIG TITTIES (hirstuism). She’s a bit of a hoar she b/c she interacts with CYP3A4 –> many drug interactions
Toxicities are numerous and include: nephrotoxicity, tremor, hypertension, hyperglycemia, hyperlipidemia, osteoporosis, **_hirsutism, gum hyperplasia.**_
_***Nephrotoxicity_ is limiting and occurs in the majority of patients treated. ****
It is the major indication for cessation or modification of therapy.
Cyclosporine causes very little bone marrow toxicity.
DRUG INTERACTIONS
Cyclosporine is primarily metabolized by CYP3A4; therefore it is involved in many drug interactions.
TACROLIMUS
CALCINEURIN INHIBITOR = T CELL INHIBITOR
TACROLIMUS –> like getting a TAC in your skin then squeezing a LIME on top —> is used to treat atopic dermatitis + psoriasis. When you squeeze the lime on, it makes you scream FK!!!!! Lime had vitamin C –> make you think of calcineurin
–> can also think T for TOPICAL and T cell inhibitor and affects the TOP (neurotoxicity is an AE)
- Tacrolimus binds to FK-binding protein (FKBP).
- FKBP is an IMMUNOPHILIN
- The tacrolimus-FKBP complex inhibits calcineurin.
USES:
1) Prevention of rejection of transplanted kidney/liver/heart
2) topical formulation is used for ATOPIC DERMATITIS + PSORIASIS
ADVERSE EFFECTS: nephrotoxicity, neurotoxicity, hyperglycemia, hypertension, HYPERkalemia, GI complaints
SIROLIMUS
PROLIFERATION SIGNAL INHIB = T CELL INHIBITOR
SIR, LIME US please. Note is not the TACrolimus, so is not used for skin. Think of a surgeon saying “SIR-LIME-US” –> used for CORONARY STENT for a RESTENOSIS –> does this all by inhibiting the SERINE-threonine kinase mTOR (SURGEON WORKS IN TORONTO)
- Structurally similar to tacrolimus.
- Sirolimus binds to FKBP .
- But the sirolimus-FKBP complex does not inhibit calcineurin.
Instead, it i_nhibits the serine-threonine kinase ***mTOR.****_
Blockade of mTOR blocks IL-2-driven T-cell proliferation.
USES:
1) RENAL TRANSPLANTATION
2) SIROLIMUS-ELUTING CORONARY STENTS are used to inhibit REstenosis of the blood vessels in patients with severe CAD by decreasing cell proliferation
ADVERSE EFFECTS: hypertriglyceridemia, pneumonitis, headache
THALIDOMIDE
INHIBITOR OF ANGIOGENESIS
T-HAL –> can think of TOM HALL –> is huge, so angiogenesis, but you want to inhibit that behavior. This drug also inhibits TNF-alpha which is for wasting, and his mother has breast cancer, so this makes sense. Thinking of mother from T hall, you can double the M for mom and get MM. Also used for Leprosy because his mom’s eyes kind of look like a leapord.
- Its mechanism of action is unclear.
Inhibits synthesis of TNF-α AND inhibits ANGIOGENESIS
Thalidomide is now called an immunomodulatory drug.
Uses:
–> indicated for the treatment of patients with
- 1) ERYTHEMA NODOSUM LEPROSUM +
- _2) MULTIPLE MYELOMA*****_
AZATHIOPRINE
ANTIMETABOLITE (CYTOTOXIC AGENT)
AZ-“PRINE” = purine w/o the U –> is a PRODRUG b/c goes from A–>Z
–> gets conerted to 6-MP (purine is 6 letters long) –> suppresses B AND T function because does from A –> Z
-Purine antimetabolite.
–> Prodrug of 6-mercaptopurine that gets converted to 6-MP
–> 6-MP is converted to metabolites that inhibit de novo PURINE nucleotide synthesis
This leads to _suppression of *B AND T* cell function, of immunoglobulin production and of IL-2 secretion._
USES:
1) prevention of organ transplant rejection
2) severe rheumatoid arthritis
ADVERSE EFFECTS: bone marrow suppressoin, GI distrubances, increase in infectious + malignancies
AZATHIOPRINE
DRUG INTERACTION
DRUG INTERACTIONS** ON EXAM:
ALLOPURINOL –> XANTHINE (almost full alphabet) –> can help you remember the AZATHIOPRINE
much of the drug’s inactivatoin depends on XANTHINE OXIDASE –> patients who are also receiving allopurinol for control of hyperuricemia should have the dose of azothiprine reduced
–> allopurinol increases concentration by inhibiting xanthine oxidase
METHOTREXATE
MOA
ANTIMETABOLITE (A CYTOTOXIC DRUG)
MethoTrex –> she’s on her Trex to go get her meth. so she screams out AI, CAR!!!
–> she usually gets that PURE stuff from her pimp, but she is on the steets now, and is yelling, so she is AMP’d UP!!! –> ADENOSINE –> then is a potent inhibitor of inflammation (when she’s amp’d up, not attractive, is anti-inflammatory)
MOA:
Methotrexate’s main mechanism of action at the low doses used in rheumatic diseases is inhibition of (AICAR) transformylase. (aminoimidazolecarboxamide ribonucleotide transformylase)
• AICAR transformylase normally catalyzes the final steps in de novo PURINE BIOSYNTHESIS which lead to synthesis of IMP.
-Inhibition of AICAR transformylase **_leads to accumulation of AMP.**_
AMP is released and converted extracellularly to adenosine
- ADENOSINE is a POTENT INHIBITOR OF INFLAMMATION
METHOTREXATE
ADVERSE EFFECTS
CONTRAINDICATIONS
USES
ANTIMETABOLITE (A CYTOTOXIC DRUG)
METH-TREX –> she’s a heavy drinker too –> hepatotoxicity –> also is contraindicated in pregnancy (obviously)
AE: nausea, mucosal ulcers, leukopenia, anemia, GI ulcerations, hepatotoxicity, cirrhosis is rare, hypersensitivity pneumonitis
-toxicity can be reduced with LEUCOVORIN or FOLIC ACID
NOTE: METHOTRAXATE is CONTRAINDICATED in pregnancy
USES:
1) RA
2) PSORIASIS
3) PSORIATIC ARTHRITIS
4) ANKYLOSING SPONDYLITIS
5) SYSTEMIC LUPUS ERYTHEMATOSUS
MYCOPHENOLATE MOFETIL
ANTIMETABOLITE (CYTOTOXIC DRUG)
Double M –> inhibits BOTH B + T lymphocyte activation. Inhibits IMP DEHYDROGENASE, the de novo pathway of PURINE synthesis (pure b/c is MM) and inhibits iMp Dehydrogenase. Aderse effect is MYELOsuppression
-mycophenolate mofetil is converted into MYCOPHENOLIC ACID
–> mycophenolic acid INHIBITS IMP DEHYDROGENASE, an enzyme in the DE NOVO pathway of GTP synthesis (PURINE SYNTHESIS)
-suppreses BOTH B+T LYMPHOCYTE ACTIVATION
–> lymphocytes are particularly susceptible to inhibitors of the de novo pathway b/c they lack the enzymes necessary for the salvage pathway
USES: 1) Prophylaxis of TRANSPLANT REJECTION, 2) SLE
AE: nausea, vomiting, diarrhea, abdominal pain, headache, HTN, REVERISBLE MYELOSUPPRESION
LEFLUNOMIDE
PRODRUG of teriflunomide.
LeflUUUUUUnOOOOOOmide
–> decreases levels of UMP by saying NOOOOOO using dihydroOOROTATE
–> must check LFT!!! (looks like LeFlunomide) –> is TERATOGENIC in animals
Teriflunomide inhibits dihydroorotate dehydrogenase.
This decreases levels of UMP. (UMP is essential for the synthesis of PYRIMIDINES)
USES: 1) RA 2) SLE 3) MYASTHENIA GRAVIS
AE: diarrhea, reversible alopecia (immune system attacking hair), rash, myelosuppression, increases in aminotransferase activity
–> CBC and LIVER FUNCTION TESTS should be MONITORED
–> is CARCINOGENIC + TERATOGENIC in animals
–> is CONTRAINDICATED IN PREGNANCY